About: DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.94 (-1.68%)
DBVT NASDAQ DBV Technologies
DBV Technologies share price
DBVT price activity
Last Price
$9.940
Change (24hr)
-0.17 USD (1.68%)
Volume
378.31K
Volume (4w avg)
-
Open
$10.04
Day Range
$9.76 - $10.41
Previous Close
$10.11
Last Trade
04 Nov, 9:00 pm GMT+0
Delayed
04 Nov, 9:00 pm GMT+0
DBVT price performance
Delayed
04 Nov, 9:00 pm GMT+0
DBVT details
DBVT Market Signals